Atara Biotherap (ATRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 3,453 | 17,575 | 98,149 | 32,753 | 40,190 |
| Cost of Goods | 115 | 554 | 20,439 | 6,795 | 7,602 |
| Gross Profit | 3,338 | 17,021 | 77,710 | 25,958 | 32,588 |
| Operating Expenses | 7,027 | 14,378 | 39,347 | 38,956 | 54,947 |
| Operating Income | -3,574 | 3,197 | 38,802 | -12,203 | -21,757 |
| Interest Expense | 909 | 972 | 1,017 | 1,017 | 1,183 |
| Other Income | 208 | 165 | 225 | 508 | 1,014 |
| Pre-tax Income | -4,275 | 2,390 | 38,010 | -12,712 | -21,926 |
| Income Tax | 28 | 3 | N/A | -19 | -17 |
| Net Income Continuous | -4,303 | 2,387 | 38,010 | -12,693 | -21,909 |
| Net Income | $-4,303 | $2,387 | $38,010 | $-12,693 | $-21,909 |
| EPS Basic Total Ops | -0.32 | 0.20 | 3.53 | 0.27 | -2.93 |
| EPS Basic Continuous Ops | -0.32 | 0.20 | 3.53 | 0.28 | -2.93 |
| EPS Diluted Total Ops | -0.32 | 0.19 | 3.50 | 0.27 | -2.93 |
| EPS Diluted Continuous Ops | -0.32 | 0.19 | 3.50 | 0.28 | -2.93 |
| EPS Diluted Before Non-Recurring Items | -0.32 | 0.19 | 3.50 | -1.19 | -2.93 |
| EBITDA(a) | $-3,621 | $3,432 | $40,856 | $-11,313 | $-20,584 |